Drug–drug interactions & the potential impact on toxicity levels in patients with B-cell malignancy
Reinforcing transplantation with consolidation therapy in Hodgkin lymphoma
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
Advances in multiple myeloma: a collaborative effort
Improving the NICE drug approval process